ACXP
ACXP
NASDAQ · Biotechnology

Acurx Pharmaceuticals Inc

$1.34
-0.02 (-1.47%)
As of Sep 28, 10:45 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,371.6% upside
Low Target $18.07
Average Target $19.72
High Target $32.84
Current Price $1.34
Current
$1.34
Target
$19.72
$18.07 $19.72 avg $32.84
Scenario Analysis
Bear Case
$18.07
1,248.5%
Low target
Base Case
$19.72
+1,371.6%
Avg target
Bull Case
$32.84
+2,350.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$8.34
-83.9% from high
52-Week Low
$1.31
+2.7% from low
Target vs 52W High
$19.72
+136.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%